Faes Farma to Acquire SIFI to Build Leading Ophthalmology Franchise

Lupin to Acquire VISUfarma from GHO Capital

September 29, 2025

Pharmaceuticals

Lupin Limited, through its wholly owned subsidiary Nanomi B.V., has signed a definitive agreement to acquire VISUfarma B.V., a pan-European ophthalmology specialty pharmaceutical business. The deal is expected to close by the end of 2025, subject to customary closing conditions, and will expand Lupin’s specialty ophthalmology presence across major European markets.

Azelis Acquires Azienda Chimica e Farmaceutica (ACEF)

July 9, 2025

Industrial Services

Azelis Group NV has acquired 100% of Azienda Chimica e Farmaceutica (ACEF), a Piacenza-based distributor of specialty raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharmaceutical markets. The acquisition strengthens Azelis's footprint in Italy, expands its product portfolio and technical capabilities, and brings ACEF's laboratories and GMP-compliant facilities into Azelis's network.

EssilorLuxottica to Acquire Optegra Eye Clinics from MidEuropa

May 30, 2025

Healthcare Services

EssilorLuxottica has agreed to acquire Optegra, a European ophthalmology platform operating over 70 eye hospitals and diagnostic facilities across the UK, Czech Republic, Poland, Slovakia, and the Netherlands. The deal follows Optegra’s expansion under MidEuropa’s ownership and is expected to close later in 2025, pending regulatory approvals and customary closing conditions.

Roquette To Acquire IFF Pharma Solutions in Up to $2.85 Billion Deal

March 20, 2024

Pharmaceuticals

IFF has entered into a definitive agreement to sell its Pharma Solutions business unit to Roquette for an enterprise value of up to $2.85 billion. The transaction is expected to close in the first half of 2025, subject to customary closing conditions and regulatory approvals.

MidEuropa Acquires Majority Stake in Optegra Eye Health Care

February 22, 2023

Healthcare Services

MidEuropa has completed the acquisition of a majority stake in Optegra Eye Health Care from H2 Equity Partners, with H2 and Optegra management reinvesting alongside MidEuropa. Optegra is a multi‑national ophthalmology platform operating 29 specialist facilities across the UK, Poland, Czech Republic and Slovakia and performs over 100,000 surgical procedures per year; MidEuropa intends to accelerate the company’s geographic expansion and growth across Europe.

Precision Medicine Group Acquires Project Farma

January 14, 2021

Healthcare Services

Precision Medicine Group has acquired Project Farma, a bioengineering services firm specializing in biomanufacturing strategy and facility implementation with a focus on cell and gene therapies. The deal brings Project Farma's manufacturing and scale-up expertise into Precision's cell and gene therapy services (Precision ADVANCE) to expand end-to-end development, manufacturing, and commercialization capabilities.